DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
about
DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
DS-1205c With Osimertinib for ...... ant Non-Small Cell Lung Cancer
@en
type
label
DS-1205c With Osimertinib for ...... ant Non-Small Cell Lung Cancer
@en
prefLabel
DS-1205c With Osimertinib for ...... ant Non-Small Cell Lung Cancer
@en
P6153
P1476
A Multicenter, Open-Label Phas ...... ant Non-Small Cell Lung Cancer
@en
P17
P3098
NCT03255083
P4844
P580
2019-04-10T00:00:00Z
P582
2021-06-15T00:00:00Z